Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells

Introduction The phenotype and function of immune cells infiltrating the conjunctiva in scarring trachoma have yet to be fully characterized. We assessed tissue morphology and immunophenotype of cellular infiltrates found in trachomatous scarring compared to control participants. Methodology Clinical assessments and conjunctival biopsy samples were obtained from 34 individuals with trachomatous scarring undergoing trichiasis surgery and 33 control subjects undergoing cataract or retinal detachment surgery. Biopsy samples were fixed in buffered formalin and embedded in paraffin wax. Hematoxylin and eosin (H&E) staining was performed for assessment of the inflammatory cell infiltrate. Immunohistochemical staining of single markers on individual sections was performed to identify cells expressing CD3 (T-cells), CD4 (helper T-cells), CD8 (suppressor/cytotoxic T-cells and Natural Killer, NK, cells), NCR1 (NK cells), CD20 (B-cells), CD45 (nucleated hematopoietic cells), CD56 (NK and T-cells), CD68 (macrophages/monocytes) and CD83 (mature dendritic cells). The degree of scarring was assessed histologically using cross-polarized light to visualize collagen fibres. Principle Findings Scarring, regardless of clinical inflammation, was associated with increased inflammatory cell infiltrates on H&E and CD45 staining. Scarring was also associated with increased CD8+ and CD56+ cells, but not CD3+ cells, suggestive of a NK cell infiltrate. This was supported by the presence of NCR1+ cells. There was some increase in CD20+ cells, but no evidence for increased CD4+, CD68+ or CD83+ cells. Numerous CD45 negative cells were also seen in the population of infiltrating inflammatory cells in scarred conjunctiva. Disorganization of the normal collagen architecture was strongly associated with clinical scarring. Conclusions/Significance These data point to the infiltration of immune cells with a phenotype suggestive of NK cells in conjunctival trachomatous scarring. A large proportion of CD45 negative inflammatory cells were also present. Future work should seek to understand the stimuli leading to the recruitment of these cells and their role in progressive scarring.

[1]  P. Andersen,et al.  Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein. , 2015, The Journal of infectious diseases.

[2]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[3]  P. Khaw,et al.  Pathogenesis of Progressive Scarring Trachoma in Ethiopia and Tanzania and Its Implications for Disease Control: Two Cohort Studies , 2015, PLoS neglected tropical diseases.

[4]  T. Fehniger,et al.  Human Cytokine-Induced Memory-Like Natural Killer Cells , 2015, Journal of Innate Immunity.

[5]  E. Riley,et al.  Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens , 2014, Immunology.

[6]  M. Burton,et al.  Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3 , 2014, PLoS neglected tropical diseases.

[7]  I. Cree,et al.  In vivo confocal microscopy and histopathology of the conjunctiva in trachomatous scarring and normal tissue: a systematic comparison , 2013, British Journal of Ophthalmology.

[8]  H. Weiss,et al.  In Vivo Confocal Microscopy in Scarring Trachoma , 2011, Ophthalmology.

[9]  Jeffrey N. Martin,et al.  Altered distribution of mucosal NK cells during HIV infection , 2011, Mucosal Immunology.

[10]  H. Weiss,et al.  Bacterial infection in scarring trachoma. , 2011, Investigative ophthalmology & visual science.

[11]  R. Rank,et al.  Essential Role for Neutrophils in Pathogenesis and Adaptive Immunity in Chlamydia caviae Ocular Infections , 2011, Infection and Immunity.

[12]  M. Koch,et al.  Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines , 2011, Clinical Cancer Research.

[13]  P. Emerson,et al.  Conjunctival Transcriptome in Scarring Trachoma , 2010, Infection and Immunity.

[14]  M. Burton,et al.  Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities , 2010, PLoS neglected tropical diseases.

[15]  T. Freeman,et al.  Human Conjunctival Transcriptome Analysis Reveals the Prominence of Innate Defense in Chlamydia trachomatis Infection , 2010, Infection and Immunity.

[16]  A. Aguzzi,et al.  Characterizing follicular dendritic cells: A progress report , 2010, European journal of immunology.

[17]  T. Darville,et al.  Pathogenesis of genital tract disease due to Chlamydia trachomatis. , 2010, The Journal of infectious diseases.

[18]  M. Burton,et al.  Epidemiology and control of trachoma: systematic review , 2010, Tropical medicine & international health : TM & IH.

[19]  N. Dalbeth,et al.  The natural killer cell: a further innate mediator of gouty inflammation? , 2010, Immunology and cell biology.

[20]  B. Munoz,et al.  Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania. , 2009, Ophthalmology.

[21]  W. Morice.  The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders. , 2007, American journal of clinical pathology.

[22]  M. Caligiuri,et al.  Human natural killer cell development , 2006, Immunological reviews.

[23]  F. Blanco,et al.  Follicular Dendritic Cells Are Related to Bone Marrow Stromal Cell Progenitors and to Myofibroblasts1 , 2006, The Journal of Immunology.

[24]  M. Burton,et al.  The long-term natural history of trachomatous trichiasis in the Gambia. , 2006, Investigative ophthalmology & visual science.

[25]  L. Missotten,et al.  Expression of growth factors in the conjunctiva from patients with active trachoma , 2006, Eye.

[26]  S. Morrison,et al.  A Predominant Role for Antibody in Acquired Immunity to Chlamydial Genital Tract Reinfection1 , 2005, The Journal of Immunology.

[27]  M. Burton,et al.  A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia , 2005, British Journal of Ophthalmology.

[28]  M. Matyszak,et al.  Infection of epithelial and dendritic cells by Chlamydia trachomatis results in IL-18 and IL-12 production, leading to interferon-gamma production by human natural killer cells. , 2005, FEMS immunology and medical microbiology.

[29]  R. Brunham,et al.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.

[30]  M. Wills,et al.  Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis , 2004, Clinical and experimental immunology.

[31]  C. Andrews,et al.  Toll-Like Receptor-2, but Not Toll-Like Receptor-4, Is Essential for Development of Oviduct Pathology in Chlamydial Genital Tract Infection 1 , 2003, The Journal of Immunology.

[32]  M. Caligiuri,et al.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. , 2003, Blood.

[33]  S. Morrison,et al.  Resolution of Secondary Chlamydia trachomatis Genital Tract Infection in Immune Mice with Depletion of Both CD4+ and CD8+ T cells , 2001, Infection and Immunity.

[34]  B. Munoz,et al.  Progression of active trachoma to scarring in a cohort of Tanzanian children , 2001, Ophthalmic epidemiology.

[35]  H. Caldwell,et al.  Immunity to Murine Chlamydia trachomatis Genital Tract Reinfection Involves B Cells and CD4+ T Cells but Not CD8+ T Cells , 2000, Infection and Immunity.

[36]  G. Aslan,et al.  A Survey of Trachoma: The Histopathology and the Mechanism of Progressive Cicatrization of Eyelid Tissues , 2000, Ophthalmologica.

[37]  G. Opdenakker,et al.  Expression of gelatinase B in trachomatous conjunctivitis , 2000, The British journal of ophthalmology.

[38]  B. Munoz,et al.  Incidence of trichiasis in a cohort of women with and without scarring. , 1999, International journal of epidemiology.

[39]  R. Rank,et al.  Role of NK Cells in Early Host Response to Chlamydial Genital Infection , 1998, Infection and Immunity.

[40]  L. Missotten,et al.  Immunopathogenesis of conjunctival scarring in trachoma , 1998, Eye.

[41]  M. Hingorani,et al.  Characterisation of the normal conjunctival leukocyte population. , 1997, Experimental eye research.

[42]  M. Thomas,et al.  The leukocyte common antigen, CD45 and other protein tyrosine phosphatases in hematopoietic cells. , 1993, Seminars in cell biology.

[43]  H. Whittle,et al.  Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. , 1993, The Journal of infectious diseases.

[44]  H. Whittle,et al.  The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective , 1993, Epidemiology and Infection.

[45]  A. Hidayat,et al.  The histopathology and the mechanism of entropion in patients with trachoma. , 1993, Ophthalmology.

[46]  C. Foster,et al.  The T cell receptor in normal and inflamed human conjunctiva. , 1992, Investigative ophthalmology & visual science.

[47]  J. Whittum-Hudson,et al.  T cells and trachoma. Their role in cicatricial disease. , 1991, Ophthalmology.

[48]  J. J. van den Oord,et al.  Immunopathology of trachomatous conjunctivitis. , 1989, The British journal of ophthalmology.

[49]  R. Wieczorek,et al.  Lymphocytic subpopulations in the normal human conjunctiva. A monoclonal antibody study. , 1986, Ophthalmology.

[50]  C. Foster,et al.  T-cell subsets and Langerhans cells in normal and diseased conjunctiva. , 1982, American journal of ophthalmology.

[51]  C. Abrahams,et al.  The pathology of trachoma in a black South African population. Light microscopical, histochemical and electron microscopical findings. , 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[52]  G. Trinchieri,et al.  Human natural killer cells. , 1979, Transplantation proceedings.

[53]  A. Silverstein,et al.  The immunologic modulation of infectious disease pathogenesis. Friedenwald Lecture, 1973. , 1974, Investigative ophthalmology.

[54]  L. Collier,et al.  The serum and conjunctival antibody response to trachoma in Gambian children , 1972, Epidemiology and Infection.

[55]  B. Maythar,et al.  Local and humoral chlamydial antibodies in trachoma patients of different age groups. , 1972, Investigative ophthalmology.

[56]  WHO Alliance for the Global Elimination of Blinding Trachoma by the year 2020. Progress report on elimination of trachoma, 2013. , 2014, Releve epidemiologique hebdomadaire.

[57]  P. B. Taylor,et al.  Conjunctival lymphocyte subsets in trachoma , 2004, International Ophthalmology.

[58]  R. Stephens.  The cellular paradigm of chlamydial pathogenesis. , 2003, Trends in microbiology.

[59]  L. Missotten,et al.  Collagen content and types in trachomatous conjunctivitis , 1998, Eye.

[60]  L. Missotten,et al.  An immunohistochemical study of collagens in trachoma and vernal keratoconjunctivitis , 1998, Eye.

[61]  C. Dawson,et al.  Guide to trachoma control in programmes for the prevention of blindness , 1981 .

[62]  Research Online , 2022 .